Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IDEntifying pAtients With Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) - Pivotal Study

NCT05108883 is registered in ClinicalTrials.gov with Brahms AG as lead sponsor.

NCT NCT05108883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05108883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IDEntifying pAtients With Suspicion of Infection in the ED Who Have Low Disease Severity Using Midregional Proadrenomedullin (MR-proADM) - Pivotal Study
Lead sponsor
Brahms AG
Phase
Not applicable
Overall status
Completed
Start date
October 14, 2021
Completion date
November 7, 2023
Enrollment
463 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

patients presenting with suspicion of infection to the ed